Isabelle Borget

Papers

Total Citations

H-Index

About

Isabelle Borget is a leading health economist whose research focuses on the economic evaluation of innovative cancer therapies, with a particular emphasis on cost-utility analyses and comparative effectiveness in oncology. Her work provides crucial evidence for healthcare decision-making, especially in the context of emerging technologies. A key contribution is her landmark study comparing robot-assisted surgery versus robotic stereotactic body radiotherapy for prostate cancer, a cost-utility analysis that directly informs treatment choices for the most common cancer among men in France. This work, which has garnered significant attention, demonstrates her commitment to integrating clinical outcomes with economic impacts to optimize patient care. Beyond this, Dr. Borget’s research portfolio consistently addresses the financial sustainability of advanced medical interventions, making her a vital voice in the field of health technology assessment. Her rigorous analyses are instrumental for clinicians, policymakers, and researchers seeking to balance innovation with cost-effectiveness in cancer care.